Clinical Trials
21 trialsNCT03740165 2026-05-04
KEYLYNK-001
Merck Sharp & Dohme LLC
Phase 3 Completed
NCT03142334 2026-03-10
KEYNOTE-564
Merck Sharp & Dohme LLC
Phase 3 Completed
NCT03221426 2026-03-09
KEYNOTE-585
Merck Sharp & Dohme LLC
Phase 3 Completed
NCT04882241 2026-03-06
KEYNOTE-585
Merck Sharp & Dohme LLC
Phase 3 Completed
NCT03635567 2026-02-04
KEYNOTE-826
Merck Sharp & Dohme LLC
Phase 3 Completed
NCT00210210 2025-09-19
KETAMINE
Institut Bergonié
Phase 3 Completed
NCT03834506 2025-07-18
KEYNOTE-921
Merck Sharp & Dohme LLC
Phase 3 Completed
NCT06910514 2025-04-09
Efficacy and Safety of a Solution for Endoscopic Mucosal Resection of Colonic Lesions
Nakafarma S.L.
Phase 3 Completed
NCT02043678 2025-02-19
ERA 223
Bayer
Phase 3 Completed
NCT03515837 2024-11-22
MK-3475-789
Merck Sharp & Dohme LLC
Phase 3 Completed
NCT02578680 2024-09-20
MK-3475-189
Merck Sharp & Dohme LLC
Phase 3 Completed
NCT04799249 2024-08-01
PRESERVE 2
G1 Therapeutics, Inc.
Phase 3 Completed
NCT03950674 2024-06-10
MK-3475-189
Merck Sharp & Dohme LLC
Phase 3 Completed
NCT01685398 2023-09-21
Topical Timolol for Superficial Infantile Hemangioma
Mahidol University
Phase 3 Completed
NCT03066778 2022-10-03
KEYNOTE-604
Merck Sharp & Dohme LLC
Phase 3 Completed
NCT02453334 2021-05-11
IRON CLAD
American Regent, Inc.
Phase 3 Completed
NCT01715597 2017-10-31
Study on the Effect of Intravenous Ascorbic Acid on Intraoperative Blood Loss in Women With Uterine Myoma
Seoul National University Hospital
Phase 3 Completed
NCT01725789 2016-12-16
Ferinject® Assessment In GastRectomy Patients With Acute Isovolemic Anemia (FAIRY)
National Cancer Center, Korea
Phase 3 Completed
NCT02314806 2014-12-11
Gentamicin Versus Clindamycin Versus Normal Saline Lavage in Axilla
Hospital General Universitario Elche
Phase 3 Completed
NCT00583323 2014-08-21
Diphenoxylate / Atropine to Decrease FDG Activity During F-18 FDG PET
Mayo Clinic
Phase 3 Completed
NCT00951574 2012-02-01
Prevention of Venous and Arterial Thromboembolism, in Cancer Patients Undergoing Chemotherapy, With a Low Molecular Weight Heparin (Nadroparin Calcium)
Italfarmaco
Phase 3 Completed